Extremely Low Dose of Erythropoiesis-Stimulating Agent May Be Associated with Increased Mortality in Hemodialysis Patients
Journal
American journal of nephrology
Journal Volume
54
Journal Issue
1-2
Date Issued
2023
Author(s)
Yang, Cheng-Wen
Lin, Mei-Chen
Shu, Kai-Hsiang
Tung, Kuei-Tung
Tsai, Wan-Chuan
Yang, Ju-Yeh
Pai, Mei-Fen
Wu, Hon-Yen
Chiu, Yen-Ling
Peng, Yu-Sen
Hsu, Shih-Ping
Wang, Shi-Heng
Abstract
Although high-dose erythropoiesis-stimulating agent (ESA) has been shown to increase mortality risk and adverse cardiovascular events in hemodialysis patients, the safety of extremely low-dose ESA is unclear.
Subjects
Erythropoiesis-stimulating agent; Hemodialysis; Mortality
SDGs
Type
journal article